Details:
🗓️ Date: 2 July 2025
⏰ 4:00 – 5:00 PM CET | 3:00 – 4:00 PM GMT
🔗 Register Now and Save Your Spot!
This webinar will discuss regulatory requirements for using Clinical Trial Assays and Companion Diagnostics in pharmaceutical clinical studies and share best practices for overcoming typical challenges.
Learning objectives
- Understand the regulatory requirements for using Clinical Trial Assays and Companion Diagnostic in pharma Clinical Trials in the EU and US
- Identify key considerations for CDx development pathways Companion Diagnostics, selection of diagnostic partners and use of in-house tests/LDTs
- Learn about best practices for combined studies and coordination between IVD manufacturers and pharma companies
Speakers
- Kristiane Schmidt, Team Manager IVD & Principal Consultant
- Lorry Weaver, Principal Consultant
Don’t miss this opportunity to gain actionable insights and stay ahead on regulatory challenges for Companion Diagnostics!
